Prioritization of Eleven-Nineteen-Leukemia (ENL) inhibitors as orally available drug candidates for acute myeloid leukemia

被引：0
|
作者：
Liu, Wenshe R.
Guo, Xuejiao
Alta, Sandeep
Xu, Shiqing
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2024年 / 23卷 / 12期
关键词：
D O I：
10.1158/1538-8514.CANCERCHEM24-A013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A013
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Bromodomain Inhibitors in Acute Myeloid Leukemia
    Roboz, Gail J.
    ANNALS OF HEMATOLOGY, 2017, 96 : S33 - S34
  • [12] Drug therapy for acute myeloid leukemia
    Tallman, MS
    Gilliland, DG
    Rowe, JM
    BLOOD, 2005, 106 (04) : 1154 - 1163
  • [13] Drug delivery in acute myeloid leukemia
    Kohschuetter, Johannes
    Michelfelder, Stefan
    Trepel, Martin
    EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (06) : 653 - 663
  • [14] Identification of leukemia-initiating cells in an experimental model of acute myeloid leukemia induced by MLL-ENL.
    Cozzio, A
    Ayton, PM
    Cleary, ML
    Weissman, IL
    BLOOD, 2001, 98 (11) : 836A - 836A
  • [15] Immune Checkpoint Inhibitors in Acute Myeloid Leukemia
    Bhatt, Vijaya Raj
    ONCOLOGY-NEW YORK, 2019, 33 (01): : 30 - 30
  • [16] Immune checkpoint inhibitors in acute myeloid leukemia
    Daver, Naval
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2021, 34 (01)
  • [17] Advances in the drug therapies of acute myeloid leukemia (except acute promyelocytic leukemia)
    Lin, Min
    Chen, Baoan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1009 - 1017
  • [18] The use of PARP inhibitors in acute myeloid leukemia
    Nieva, Cheenie
    Lincz, Lisa
    Skelding, Kathryn
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 34 - 34
  • [19] Menin inhibitors in the treatment of acute myeloid leukemia
    Huls, Gerwin
    Woolthuis, Carolien M.
    Schuringa, Jan Jacob
    BLOOD, 2025, 145 (06) : 561 - 566
  • [20] Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
    Liu, Xiaoyan
    Gong, Yuping
    BIOMARKER RESEARCH, 2019, 7 (01)
12345